Wellesley Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Wellesley Investment Partners's GILD Position: Q3 2020 in Review
Wellesley Investment Partners reduced its Gilead Sciences (GILD) stake by 14% in Q3 2020, selling an estimated $106K and leaving 9,250 shares worth $584K. The position accounts for 0.2% of the portfolio, ranked #55.
Wellesley Investment Partners first reported a position in GILD in Q4 2015 and has held it in 20 quarters since. The position peaked at $1.18M in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Wellesley Investment Partners held 9,250 shares of Gilead Sciences worth $584K as of Q3 2020.
- Wellesley Investment Partners sold 1,522 Gilead Sciences shares in Q3 2020, an estimated $106K.
- Gilead Sciences made up 0.2% of Wellesley Investment Partners's portfolio in Q3 2020, its #55 holding.
- Wellesley Investment Partners first reported a position in Gilead Sciences in Q4 2015 and has held it in 20 quarters since.
- Wellesley Investment Partners's Gilead Sciences position peaked at $1.18M in Q3 2018.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Wellesley Investment Partners's 13F filing for Q3 2020, filed 30 Oct 2020.